Kun Ding
Impact in
- Ophthalmology top 2%
- Retinal Diseases and Treatments
- Retinal and Optic Conditions
- Glaucoma and retinal disorders
-
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Retinal Development and Disorders 4
- Angiogenesis and VEGF in Cancer 1
-
- Retinal Diseases and Treatments 4
- Retinal and Optic Conditions 1
- Co-authors
- Jikui Shen (6 shared papers)Peter A. Campochiaro (7 shared papers)Raquel Lima e Silva (2 shared papers)Sean F. Hackett (3 shared papers)Mahmood Khan (3 shared papers)Huiming Xia (1 shared paper)Christopher D. Kontos (1 shared paper)Aling Dong (1 shared paper)
- Journals
- Journal of Clinical Investigation (2 papers)Chemico-Biological Interactions (1 paper)Gene Therapy (1 paper)Journal of Molecular Medicine (1 paper)Science Advances (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Kun Ding
13 papers receiving 396 citations
Peers
Comparison fields: 5 of 61
- Ophthalmology 167
- Cancer Research 53
- Molecular Biology 254
- Radiology, Nuclear Medicine and Imaging 77
- Neurology 15
Countries citing papers authored by Kun Ding
This map shows the geographic impact of Kun Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kun Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kun Ding more than expected).
Fields of papers citing papers by Kun Ding
This network shows the impact of papers produced by Kun Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kun Ding. The network helps show where Kun Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Kun Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 164 | |
| 2 | 2019 | 109 | |
| 3 | 2020 | 47 | |
| 4 | 2016 | 41 | |
| 5 | 2021 | 11 | |
| 6 | 2023 | 11 | |
| 7 | Gpc-3 is a notable diagnostic, prognostic and a latent targeted therapy marker in hepatocellular carcinoma. | 2011 | 9 |
| 8 | 2021 | 7 | |
| 9 | 2021 | 7 | |
| 10 | 2022 | 2 | |
| 11 | Transgene Expression in RPE and Retina after Suprachoroidal delivery of AAV vectors | 2020 | 2 |
| 12 | The HIF-1 inhibitor acriflavine is visualized in retina after multiple modes of administration/doses that suppress ocular neovascularization | 2016 | 1 |
| 13 | 2021 | 1 | |
| 14 | 2026 | 1 | |
| 15 | 2025 | 0 | |
| 16 | 2025 | 0 |
About Kun Ding
Kun Ding is a scholar working on Molecular Biology, Ophthalmology, Pathology and Forensic Medicine, Genetics and Cancer Research, having authored 16 papers that have together received 413 indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (4 papers), Retinal Development and Disorders (4 papers), Ophthalmology and Eye Disorders (2 papers), Cancer-related molecular mechanisms research (2 papers), Ophthalmology and Visual Impairment Studies (1 paper), Angiogenesis and VEGF in Cancer (1 paper), High Altitude and Hypoxia (1 paper) and Retinal and Optic Conditions (1 paper). The work is most often cited by research in Ophthalmology (167 citations), Cancer Research (53 citations), Molecular Biology (254 citations), Radiology, Nuclear Medicine and Imaging (77 citations) and Neurology (15 citations). Kun Ding has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Jikui Shen, Peter A. Campochiaro, Raquel Lima e Silva, Sean F. Hackett, Mahmood Khan, Huiming Xia, Christopher D. Kontos, Aling Dong, Maike Frye and Christopher Seidel. Their work appears in journals such as Journal of Clinical Investigation, Chemico-Biological Interactions, Gene Therapy, Journal of Molecular Medicine and Science Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.